KITVEN Fund-3 (Biotech) is a SEBI registered Venture Capital Fund having target corpus of Rs. 35.55 crore. The Fund proposes to undertake investments in companies catering to Biotechnology and such other allied sectors within the State of Karnataka. Currently, the Fund has received commitment from State and Central Government firms/ institutions like Karnataka Biotechnology & Information Technology Services (KBITS), Small Industries Development Bank of India (SIDBI) and KSIIDC BIRAC.

KITVEN Fund-3 (Biotech) undertakes investment in the range of Rs. 100 lakhs to Rs. 350 lakhs per company during the initial stage which can be enhanced upto Rs. 500 lakhs per company at a later stage / follow-on investment.

The investment in companies will be in the nature of equity, preference capital (convertible/ redeemable), debentures OR combination of any of the above instruments adhering to the guidelines issued by the Securities & Exchange Board of India (SEBI) from time-to-time. The typical investment horizon would be 3-5 years although lower periods would also be considered.

As the IP/ product development life cycle is longer in most of the biotechnology firms, the fund also seeks to co-invest along with other reputed VC / investment firms. Investment will be undertaken only in startup companies as defined in Gazette Notification GSR 180(E) dated 17.02.2016 and as amended from time-to-time.

Investment Committee Members

Investment Committee Members of KITVEN Fund-3 (Biotech) inculde :-

Name Designation
Shri Darshan H V, IAS MD, KITS
Shri Dr K K Narayan former CEO of Meta-Helix Science
Dr. Amit Aggarwa CEO of Natural Remedies
Dr Subramanyam Vangala CEO of ReaGene BioScience
Shri Seetharam Annadana Veg R&D APAC Technology Leas, Syngenta
Shri Utpal S Tatu, PhD Dept. of Biochemistry, IISc, Bangalore
Shri P V Harikrishnan CEO, KAMCO

Portfolio Units

1. Pandorum Technologies Pvt Ltd

Pandorum is a biotechnology company with a focus on tissue engineering and regenerative medicine. It brings together synergies between life sciences, engineering and clinical competences and manufactures three dimensional functional human tissues intended for medical research and therapeutics
More info at ::   Pandorum Technologies

2. String Bio Pvt Ltd

String’s innovative solution will leverage methane, produced from waste or available from natural resources to create valuable chemical monomers. These are building blocks of everyday products from biodegradable plastic to high performance polymers.
More info at ::   String Bio Pvt Ltd

3. Vipragen Biosciences Pvt Ltd

Vipragen provide contract research services in areas of Biology, Toxicology, Pharmacology, DMPK, Drug Discovery and other Pre-clinical research areas. Company revived GLP compliance certificate from Govt. of India.
More info at ::   Vipragen Biosciences Pvt Ltd

4. JIVA Sciences Pvt Ltd

Jiva is one of the front runners in India working on bovine semen sorting technology having widespread application in the dairy industry in India. Jiva’s domain expertise lies in microfluidics, lasers and automating biological processes (such as bovine embryo processing) through innovative engineering solutions.

5. Fibroheal Woundcare Pvt Ltd

“Fibroheal Woundcare Pvt Ltd” is working exclusively on advanced wound care management. The company is one among the few across the globe to work on non-textile application of “Silk Protein” as versatile biomaterial in biomedical use.
More info at ::   Fibroheal Woundcare Pvt Ltd

6. Alepa Dairy Foods Pvt Ltd

“Alepa Dairy Foods Pvt Ltd” provides single source produced, processed, packaged milk from their own farm.
More info at ::   Alepa Dairy Foods Pvt Ltd

7. NESA Medtech Pvt Ltd

“NESA Medtech Pvt Ltd” offers a scarless technology to treat uterine fibroids. NESA’s technology is a precise guidance and planning system to deliver treatment to shrink uterine fibroids leading to symptomatic relief.
More info at ::   NESA Medtech Pvt Ltd
Applications for Venture Capital assistance are invited from companies in the field of AVGC, AI, ML, Medtech, EV and such other Disruptive Technologies Venture Capital Fund